These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8470238

  • 1. Cyclosporine vs OKT3 prophylaxis after orthotopic liver transplantation.
    Pons JA, Bueno F, Parrilla P, Ramirez P, Bixquert V, Robles R, Miras M, Rodriguez J.
    Transplant Proc; 1993 Apr; 25(2):1949. PubMed ID: 8470238
    [No Abstract] [Full Text] [Related]

  • 2. High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
    Cherqui D, Duvoux C, Salvat A, Lauzet JY, Metreau JM, Julien M, Fagniez PL, Dhumeaux D.
    Transplant Proc; 1995 Feb; 27(1):1134-5. PubMed ID: 7878824
    [No Abstract] [Full Text] [Related]

  • 3. A comparison of azathioprine and cyclosporine in liver transplantation: a study of two personal series.
    Krom RA, Wiesner RH, Haagsma EB, Ludwig J, Gips CH, Grond AJ, Houthoff HJ.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2440-2. PubMed ID: 3079085
    [No Abstract] [Full Text] [Related]

  • 4. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.
    Lange D, Bechstein WO, Blumhardt G, Lemmens P, Schattenfroh N, Neuhaus P.
    Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207
    [No Abstract] [Full Text] [Related]

  • 5. OKT3 prophylaxis in liver transplant patients: a European and Australian multicenter, prospective controlled trial.
    Höckerstedt K, Ericzon BG, Bismuth H, Chapuis Y, Farges O, Faure JL, Galmarini D, Houssin D, Lynch SV, Miguet J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):556-7. PubMed ID: 8438412
    [No Abstract] [Full Text] [Related]

  • 6. Presence of different T and B-peripheral blood lymphocyte subsets in liver transplantation after cyclosporine or OKT3 immunosuppressive treatment.
    Minguela A, Alvarez-López MR, Sánchez-Bueno F, Torío A, Muro M, Robles R, Pons JA, Parrilla P, García-Alonso AM.
    Transplant Proc; 1995 Aug; 27(4):2317-8. PubMed ID: 7652825
    [No Abstract] [Full Text] [Related]

  • 7. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
    Dé P, Bechstein WO, Blumhardt G, Lange D, Schattenfroh N, Neuhaus P.
    Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Conversion from Sandimmune to Neoral in stable liver graft recipients.
    Pollard SG, Lodge JP.
    Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213
    [No Abstract] [Full Text] [Related]

  • 10. FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man.
    Söderdahl G, Groth CG, Angelin B, Duraj F, Einarsson K, Ericzon BG.
    Transplant Proc; 1995 Feb; 27(1):1125. PubMed ID: 7533362
    [No Abstract] [Full Text] [Related]

  • 11. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
    Woodle ES, Perdrizet GA, So S, Jendrisak MD, White HM, Marsh JW.
    Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
    [No Abstract] [Full Text] [Related]

  • 12. Cytomegalovirus prophylaxis with ganciclovir, acyclovir, and CMV hyperimmune globulin in liver transplant patients receiving OKT3 induction.
    Ham JM, Shelden SL, Godkin RR, Posner MP, Fisher RA.
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):31-3. PubMed ID: 7482814
    [No Abstract] [Full Text] [Related]

  • 13. Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression.
    McAlister V, Grant D, Roy A, Yilmaz Z, Ghent C, Wall W.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1400-1. PubMed ID: 8442154
    [No Abstract] [Full Text] [Related]

  • 14. Quadruple-drug therapy with antithymocyte globulin in the early postoperative period after liver transplantation.
    Schattenfroh N, Lange D, Bechstein WO, Blumhardt G, Lohmann R, Neuhaus P.
    Transplant Proc; 1993 Apr; 25(2):1968-9. PubMed ID: 8470245
    [No Abstract] [Full Text] [Related]

  • 15. Use of OKT3 for late acute rejection in liver transplantation.
    Samuel D, Gugenheim J, Canon C, Saliba F, Bismuth H.
    Transplant Proc; 1990 Aug; 22(4):1767-8. PubMed ID: 2117804
    [No Abstract] [Full Text] [Related]

  • 16. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
    Kehinde EO, Wheatley T, Feehally J, Nicholson ML, Veitch PS, Bell PR.
    Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
    [No Abstract] [Full Text] [Related]

  • 17. Intensive care after orthotopic liver transplantation.
    Sun CK, Chen CL, Kuo YC, Chen YS.
    Transplant Proc; 1994 Aug; 26(4):2246-7. PubMed ID: 7520627
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of cyclosporine dosing on creatinine levels in hepatic transplant recipients.
    Gross CR, Savik SK, Ascher NL, Gordon RD, Klintmalm GB, Payne W, Shaw BW, Strasburg K, Parker A, Wiesner RH.
    Transplant Proc; 1994 Oct; 26(5):2686-90. PubMed ID: 7940841
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group.
    Grant D, Rochon J, Levy G.
    Transplant Proc; 1996 Aug; 28(4):2232-3. PubMed ID: 8769208
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.